IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 1 Chinese biotech developing CAR-T cell therapies for cancer.
Industry: Health Care
Latest Trade: $10.25 0.00 (0.0%)
First Day Return: +31.9%
Return from IPO: -46.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/18/2020 |
Offer Price | $19.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 11.0 |
Deal Size ($mm) | $209 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/07/2021 |
Offer Price | $19.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 11.0 |
Deal Size ($mm) | $209 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Citi |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Suzhou, China |
Founded | 2017 |
Employees | 160 |
Website www.gracellbio.com |